Michael H. Mulroy insider trades: Lineage Cell Therapeutics (LCTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | LCTX | ↑ Buy | 40,000 | $0.57 | $23K | Direct | Nov 25, 2024 (3d) |
| Mar 24, 2022 | LCTX | ↑ Buy | 7,000 | $1.40 | $10K | Direct | Mar 25, 2022 (1d) |
| Aug 27, 2018 | AST | ↑ Buy10b5-1 | 3,141 | $1.59 | $5K | Direct | Aug 29, 2018 (2d) |
| Jul 25, 2018 | AST | ↑ Buy10b5-1 | 2,950 | $1.69 | $5K | Direct | Jul 27, 2018 (2d) |
| Jun 25, 2018 | AST | ↑ Buy10b5-1 | 3,067 | $1.63 | $5K | Direct | Jun 27, 2018 (2d) |
| May 25, 2018 | AST | ↑ Buy10b5-1 | 3,153 | $1.59 | $5K | Direct | May 31, 2018 (6d) |
| Apr 25, 2018 | AST | ↑ Buy10b5-1 | 3,752 | $1.33 | $5K | Direct | Apr 27, 2018 (2d) |
| Mar 26, 2018 | AST | ↑ Buy10b5-1 | 2,839 | $1.76 | $5K | Direct | Mar 28, 2018 (2d) |
| Feb 26, 2018 | AST | ↑ Buy10b5-1 | 2,255 | $2.22 | $5K | Direct | Feb 28, 2018 (2d) |
| Jan 25, 2018 | AST | ↑ Buy10b5-1 | 2,134 | $2.34 | $5K | Direct | Jan 26, 2018 (1d) |
| Dec 26, 2017 | AST | ↑ Buy | 2,247 | $2.22 | $5K | Direct | Dec 28, 2017 (2d) |
| Nov 27, 2017 | AST | ↑ Buy | 2,076 | $2.41 | $5K | Direct | Nov 29, 2017 (2d) |
| Oct 25, 2017 | AST | ↑ Buy | 1,939 | $2.55 | $5K | Direct | Oct 27, 2017 (2d) |
| Sep 25, 2017 | AST | ↑ Buy | 1,537 | $3.25 | $5K | Direct | Sep 27, 2017 (2d) |
| Aug 11, 2014 | QCOR | ↓ Sell | 10,000 | $92.33 | $923K | Direct | Aug 13, 2014 (2d) |
| Jul 10, 2014 | QCOR | ↓ Sell | 10,000 | $90.89 | $909K | Direct | Jul 14, 2014 (4d) |
| Jun 10, 2014 | QCOR | ↓ Sell | 10,000 | $88.57 | $886K | Direct | Jun 12, 2014 (2d) |
| May 12, 2014 | QCOR | ↓ Sell | 10,000 | $87.99 | $880K | Direct | May 14, 2014 (2d) |
| Apr 10, 2014 | QCOR | ↓ Sell | 10,000 | $85.04 | $850K | Direct | Apr 14, 2014 (4d) |
| Mar 10, 2014 | QCOR | ↓ Sell | 10,000 | $64.80 | $648K | Direct | Mar 12, 2014 (2d) |
| May 23, 2012 | QCOR | ↑ Buy | 1,000 | $40.00 | $40K | Direct | May 24, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LCTX insiders
Open-market trades in the last 12 months
About Michael H. Mulroy's insider trades
Michael H. Mulroy is an insider at Lineage Cell Therapeutics (LCTX). Since May 23, 2012, Michael has reported 15 open-market purchases worth $132K and 6 sales worth $5.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (25 filings), option exercises (6 filings), shares withheld for taxes (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LCTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.